Blood pressure is insufficiently controlled in European patients with established coronary heart disease

Boersma, Eric; Keil, Ulrich; D, De Bacquer; G, De Backer; Pyörälà, Kalevi; Poldermans, D; Leprotti, C; Pilotto, Lorenza; E, de Swart; Jw, Deckers; Heidrich, Jan; Sans, S.; Kotseva, Kornelia; Wood, David; Gb, Ambrosio; I, EuroAspire; Groups, II Study

doi:10.1097/00004872-200310000-00009

Cited by 75 publications

(52 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is very similar to the results in the EUROA-SPIRE II survey [16] and is representative of apparently improving blood pressure control worldwide, or at least in some centres; clearly though, much more needs to be achieved. Other studies are less optimistic, however, [17].…”

Section: Failure To Achieve Target Blood Pressuressupporting

confidence: 83%

Changes in the usage of antihypertensive drugs: implications and prospects

Schachter

2005

Brit J Clinical Pharma

View full text Add to dashboard Cite

Section: Failure To Achieve Target Blood Pressuressupporting

confidence: 83%

Changes in the usage of antihypertensive drugs: implications and prospects

Schachter

2005

Brit J Clinical Pharma

View full text Add to dashboard Cite

“…Анализ анамнестических дан-ных пациентов показывает, что значимо выше в 2009 г. стало число пациентов с перенесенным ОИМ, а так-же стенокардией напряжения. Процент распростране-ния АГ по нашим данным выше, чем в европейском ре-гистре ACS I (51,6% для ОКСПST и 63,5% для ОКСБПST) и в европейском исследовании EUROASPIRE [9]. Чис- [8] и значимо меньше ФР ОКС (89%) [1].…”

Section: Discussionunclassified

Dynamics of Acute Coronary Syndrome Patient Management in Nonivasive Primary Vascular Center (According to Record and Record-2 Registers)

Provotorov

Shevchenko

Islamov

2011

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Сердечно-сосудистые заболевания по-прежнему занимают лидирующие позиции среди причин забо-леваемости и смертности в России [1]. Среди сердеч-ных заболеваний наиболее важное место в этом ряду занимают острый инфаркт миокарда (ОИМ) и про-грессирующая стенокардия [2]. Введение в 90-х гг. тер-мина «острый коронарный синдром» (ОКС) имело, прежде всего, практическую значимость, так как поз-волило разделить пациентов на две клинические груп-пы: ОКС с подъемом (ОКСПST) и без подъема сегмен-та ST (ОКСБПST), что в свою очередь предполагает диф-ференцированную терапию уже на догоспитальном эта-пе с полной преемственностью на госпитальном. Одним из путей решения проблемы высокой летальности па-циентов с ОКС является детальный анализ факторов рис-ка, семейного анамнеза, приверженности терапии на догоспитальном этапе, а также адекватности ведения пациентов на госпитальном и постгоспитальном этапах [3,4]. В современных условиях получение подробной информации возможно в результате проведения не-рандомизированных когортных исследований -ре-гистров [4,5]. Проведение регистров ОКС широко ис-пользуется во многих странах, давая очень ценную ин-формацию, охватывающую многие аспекты парамет-ров пациентов с ОКС [6,7]. В настоящее время большое значение придается работе первичных и региональных сосудистых центров, создаваемых во многих регионах РФ [1]. ДИНАМИКА ВЕДЕНИЯ ПАЦИЕНТОВ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В НЕИНВАЗИВНОМ ПЕРВИЧНОМ СОСУДИСТОМ ЦЕНТРЕ (ПО ДАННЫМ РЕГИСТРОВ РЕКОРД И РЕКОРД-2)

show abstract

“…[1][2][3][4][5][6][7][8] These data primarily come from registries of non-ST-elevation ACS and myocardial infarction (MI) where management is highly technical and complex. [2][3][4][9][10][11] Regional differences in noncomplex CV care required for hypertension and diabetes management have also been documented. 9,[12][13][14][15][16] The reasons for regional management and outcome differences have not been fully explored, but differences in patient characteristics, variability in delivery of complex and noncomplex technology and/or guidelinedriven chronic therapies, disparity in patient adherence to treatment, and discrepancies in outcomes assessment and adjudication may contribute.…”

Section: Introductionmentioning

confidence: 99%

Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR‐Trandolapril Study (INVEST)

Zineh

Cooper‐DeHoff

Wessel

et al. 2005

Clinical Cardiology

View full text Add to dashboard Cite

Background: The INternational VErapamil SR‐Trandolapril Study (INVEST), a prospective, randomized, antihypertensive trial, found that two different medication regimens produced similar blood pressure (BP) control with equivalent cardiovascular (CV) outcomes (death from any cause, nonfatal myocardial infarction [MI], or nonfatal stroke). Hypothesis: The study was undertaken to investigate whether differences exist by global regions in demographics, treatment, and outcomes in the INVEST trial. Methods: Data were analyzed for 22,576 patients with stable coronary artery disease (CAD) enrolled in INVEST. We investigated differences in patient characteristics, treatment approaches, BP control, and clinical outcomes by creating three global regions based on geographical location: Northern Americas (NA), Caribbean (CA), and Eurasia (EA). Results: We observed significant regional differences in patient characteristics, treatment patterns, BP control, and CV outcomes. At baseline, patients from NA were older and had greater body mass index, higher rates of diabetes, peripheral vascular disease, and coronary revascularization, but lower rates of MI or left ventricular hypertrophy than patients in CA and EA. At 24 months, there were regional differences in both study and nonstudy antihypertensive drug use. Despite having higher mean baseline BP, patients from CA and EA achieved lower mean systolic BP throughout study follow‐up. Furthermore, patients from both CA and EA had lower rates of all‐cause mortality, fatal or nonfatal MI, fatal or nonfatal stroke, and newly diagnosed diabetes than patients from NA. Conclusions: In INVEST, regional differences in medication utilization, BP control, and CV outcomes were identified. These disparities warrant further investigation to define appropriate care for patients with hypertension and stable CAD from an international public health perspective.

show abstract

Blood pressure is insufficiently controlled in European patients with established coronary heart disease

Abstract: During 1995-2000 the prevalence of elevated blood pressure in patients with established coronary heart disease remained at an unacceptably high level. Throughout Europe, still about half of coronary patients require more intensive blood pressure management.

Cited by 75 publications

References 29 publications

Changes in the usage of antihypertensive drugs: implications and prospects

Changes in the usage of antihypertensive drugs: implications and prospects

Dynamics of Acute Coronary Syndrome Patient Management in Nonivasive Primary Vascular Center (According to Record and Record-2 Registers)

Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR‐Trandolapril Study (INVEST)

Contact Info

Product

Resources

About